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Total elbow arthroplasty is mostly used for elbows mutilated by rheumatoid arthritis. 
Today there is two types of TEAs used: Semi-constrained, in which parts are 
mechanically linked, and unlinked, in which components are connected only by patients 
own tissue. These prostheses provide great results for improved elbow function and pain 
relief for patients with RA. In previous studies the complication rates for TEAs are 
much higher than in other common arthroplasties such as knee or hip. Most common 
complications for TEAs are loosening of components, periprosthetic fractures and 
instability. 
In our study we analyzed long-term clinical and radiological results of three different 
models of unlinked prosthesis. Total of 53 prostheses in 48 patients were included to 
our study. All patients had RA and were operated in two Finnish hospitals between 
1997-2007. For the evaluation we used Mayo Elbow Performance Score (MEPS), range 
of motion (ROM) and radiographs taken before and after operations. Paired-Samples T-
test was used to compare pre- and postoperative results and Kaplan-Meyer survival 
analysis was used to calculate survival times. 
In our study long- term MEPS scores and ROM were significantly higher 
postoperatively. Complications and revisions were much more common and survival 
time shorter than in other common arthroplasties. TEAs provide great long-term 
improvement for the patients’ quality of life. Yet the complication and revision rates are 
high and survival time relatively short and therefore development of new TEAs is 
needed. 
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ABSTRACT 
BACKGROUND & AIMS:  Total elbow arthroplasty (TEA) is a commonly used treatment for 
severely destroyed elbows in rheumatoid arthritis (RA). Indications for TEAs also include trauma 
and osteoarthritis. The aim of this study was to evaluate long-term clinical and radiological results 
of three different unlinked total elbow prostheses. 
MATERIALS AND METHODS: We analyzed the results of 53 unlinked prostheses in 48 patients 
with rheumatoid arthritis placed in two Finnish hospitals between 1997 and 2007. The mean follow-
up time was 15.8 years. For clinical results, we used the Mayo Elbow Performance Score (MEPS) 
and range of motion (ROM). For radiological results, we used pre- and postoperative radiographs. 
For calculating the survival time, we used the Kaplan-Meyer survival analysis. 
RESULTS: MEPS scores were 30 points higher postoperatively and stayed level during the follow-
up. Improvements in ROM were also significant. Active extension motion deficiency was 6 degrees 
lower, active flexion improved by 10 degrees, forearm pronation improved by 8 degrees and 
supination improved by 8. Radiological loosening was very common in both components. The 
complication rate was 28% and revision surgery was needed with 23% of the patients. For implant 
survival, we found a mean survival time of 70 months. 
CONCLUSION: Unlinked total elbow arthroplasties provide excellent long-term results for 
improving elbow functionality and significantly increase the quality of life, but complication and 
revision rates are high. Compared to other common arthroplasties such as knee and hip 
arthroplasties TEAs have much more complications and much shorter survival times. Further 
development of TEAs is needed to decrease complication and revision rates. 
 
Keywords: arthroplasty, elbow, orthopaedic surgery, prosthesis, rheumatoid arthritis, unlinked 
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INTRODUCTION 
The first commercial total elbow arthroplasty (TEA) was introduced in 1972 for rheumatoid 
arthritis. (1) While both prostheses and surgical techniques have evolved over the last 45 years, the 
basic principle of function have remained the same. More developed models and surgical 
techniques have made it possible to use these implants also in elbow traumas and osteoarthritis. 
Despite new indications, the most common patient is 60 years old woman with rheumatoid arthritis. 
(2) Previous studies have shown that TEAs significantly improve function, the range of motion and 
stability of the elbow and greatly lessens the pain of elbow. (3) 
There are two types of prostheses in use: Semi-constrained and unlinked. In semi-
constrained models, implants are mechanically linked with so-called sloppy-hinge. In unlinked 
models, the implants are not mechanically linked together, and the stability is provided by the 
support of the patient’s own tissue.(4) To provide enough support to prevent dislocation the 
patient’s bones and ligaments must be sufficiently well preserved. Also, the function of elbow’s 
flexor and extensor muscles must be sufficient enough.(5,6) With unlinked prostheses the 
movement of the elbow is almost the same as in normal elbow and in theory, wear out less and 
reduce the risk for loosening and osteolysis.(5,7) Although the most common complications are the 
same with both types of prostheses in practice it has been shown that unlinked prostheses are more 
likely to develop complications than semi-constrained prostheses. The most common complications 
are clinical and radiological loosening, periprosthetic fractures, instability of the prosthesis, 
infection and mechanical failure. (2,3,8,9) 
Radiolucency and most complications can be detected in radiographs. Radiolucent 
lines less than one millimeter wide are accepted. During time in some cases radiolucent lines widen. 
With most patients these widen radiolucent lines doesn’t progress and the component doesn’t 
become radiologically loose. In some cases, the widening of radiolucent lines starts to progress. 
Radiolucent line wider than two millimeters indicates radiological loosening. All radiologically 
loose prostheses don’t become clinically loose. (10)  Osteolysis is a common phenomenon in 
arthroplasties and can be seen in radiographs as areas of radiolucency in the bone near the 
prostheses. Osteolysis can lead to loosening or periprosthetic fracture. Luxation, subluxation and 
polyethylene wear can be seen in radiographs as malposition of the joint. 
The aim of this study was to analyze the Mean to long-term clinical and radiological 
results of total elbow arthroplasties with three types of unlinked prostheses.  
 
MATERIALS AND METHODS 
From 1997 to 2007, a total of 53 TEAs was performed for 48 patients with rheumatoid arthritis in 
two hospitals using 19 IBP (Biomet), 30 Kudo (Biomet) and 4 Souter-Strathclyde (Stryker) 
unlinked prostheses. There were 42 women and 6 men. The mean age of patients was 61 (range 35–
86) years. Patients were evaluated preoperatively, postoperatively and at 1, 3, 5, 7, 10, 15, and 17 
years, if available. The mean follow-up of patients was 15.8 (range 3.8–20.8) years. 19 patients 
were lost because of death unrelated to the prostheses during the follow-up. Some of patients had 
undergone previous surgeries for elbow. Previous operations were either synovectomy or excision 
of capitulum radii which was common operation in that time in Finland. Previous operations have 
been excluded from this study because they didn’t have effect on outcome. The data was gathered 
from electronic patient records. Demographics are presented in Table 1.  
Clinical evaluation was made by standardized protocol by an independent observer 
preoperatively, postoperatively and during follow-up. Clinical evaluation of elbow’s function was 
made by using the Mayo Clinic Performance Scoring(11) (MEPS) and ranges of motion (ROM) of 
elbow’s extension and flexion and forearms pronation and supination. At follow-ups patients were 
also interviewed for subjective improvement of function and overall satisfaction of the results with 
a scale of 1 to 4, where 1 was worse than preoperatively, 2 was no effect, 3 was slightly better and 4 
was much better than preoperatively. 
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Preoperative radiological evaluation of elbows was made by using Larsen’s grading 
(12). In the scale for 1 to 5, all the patients had a degree of destruction from level 3 to 5 or from 
medium destructive abnormalities to severe mutilation. The average Larsen’s grade was 4.0 while 
the range was from 3 to 5. Postoperative radiological results were evaluated by searching 
radiolucency lines from radiographs. Ulnar and humeral components were both divided into four 
areas to define the location of radiolucent lines. (Fig. 1: Areas for radiolucency) Preoperative 
information is presented in Table 1.  
The elbow prostheses were chosen for treatment because it is the number one choice 
for mutilated elbows in Finland. Unlinked prostheses were chosen because they were commonly 
used in Finland in that time for patients with RA, later semi linked prostheses have taken their 
place. The medical treatment of RA has varied highly during the follow-up; therefore, medication 
has been excluded from the study. In Finland the treatment of RA begins with combination therapy 
(13) and other drugs are added afterwards if needed. In Finland biological drugs have been available 
for treatment of RA only since early 2000s. 
 
STATISTICAL METHODS 
For calculating implant survival rates Kaplan-Meyer survival analysis was used while revision 
surgery was the endpoint. Differences between preoperative and postoperative of clinical results 
were compared with Paired-Samples T-test and considered significant if the P value was <0.05 on a 
2-tailed test. SPSS Statistics software version 20.5 (IBM SPSS Statistics 25) was used for statistical 
analysis. 
 
RESULTS 
Clinical results are presented in Table 2. The MEPS scores improved significantly after the 
operation and remained at the same levels in the follow-up. In this study, the improvement of MEPS 
after the operation was 30 points (95% confidence interval (CI), 23–36, P<0.0001, N=50). The 
preoperative mean of MEPS was 56 (15–100) and postoperatively the mean was 86 (35–100). No 
patient had worse MEPS postoperatively than preoperatively. 
MEPS scores were also evaluated during the follow-up. In the follow-up means were: 
95 (45–100, N=47) after 1 year, 91 (35–100, N=41) after 3 years, 96 (65–100, N=35) after 5 years, 
88 (40–100, N=18) after 7 years, 86 (100–60, N= 15) after 10 years, 85 (100–65, N=4) after 15 
years and 80 (N=1) after 17 years. (Fig. 2: The mean MEPS during follow up) 
The ranges of motion of the elbow and the forearm were also significantly higher 
postoperatively in this study. Active extension motion deficiency was 6 degrees lower (95% CI, 2–
10, P<0.002, N=50). For extension deficiency, the preoperative mean was 30 (10–70) degrees and 
postoperatively 24 (0–60) degrees. Active flexion improved by 10 degrees (95% CI, 6–14, P<0.001, 
N=50) while the preoperative mean for flexion was 127 (75-150) degrees and the postoperative 
mean was 137 (105–155) degrees. Forearm pronation improved by 8 degrees (95% CI, 2–13, 
P<0.005, N=50). Forearm pronation was 73 (30–95) degrees preoperatively and 80 (30–100) 
degrees postoperatively. Forearm supination improved by 8 degrees (95% CI, 2–14, P<0.007, 
N=50) degrees while the means were 67 (5–100) degrees for preoperative and 74 (10–100) degrees 
for postoperative supination. 
The satisfaction and the patients’ own estimation of the improvement of daily function 
were also very high. Most of the patients had great results even after the latest follow-up. None of 
the patients reported worse function than preoperatively. In the scale from 1 to 4 where 1 was worse 
than preoperatively, 2 was no effect, 3 was slightly better and 4 was much better than 
preoperatively, the mean for patient satisfaction was 3.6 (2–4) and the mean for improvement of 
daily function was 3.6 (2–4). 
Radiological results are presented in Table 2. At the follow-up, study radiolucency 
was observed in all four areas for both components. For ulnar component radiolucency was 
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observed for 10 (19%) TEAs in the 1st area, for 3 (6%) in the 2nd area, for 2 (4%) in the 3rd area 
and 2 (4%) in the 4th area. For humeral component radiolucency was observed for 12 (23%) TEAs 
in the 1st area, for 5 (9%) in the 2nd area, for 2 (4%) in the 3rd area and for 1 (2%) in the 4th area. 
The component was radiologically loose if radiolucency was present in 3rd or 4th area. 
Radiological results are presented in Table 2. 
 
COMPLICATIONS 
In this study, complications were observed in 15 (28%) elbows. Complications included aseptic 
loosening of the component in 6, luxation in 3, subluxation in 2, dehiscence of triceps tendon in 1, 
periprosthetic fracture in 1, polyethylene wear in 1 and infection in 1 cases. Radiological loosening 
was observed in 8% of the ulnar and 6% of the humeral components. 
Revision surgery was needed in 12 cases (23%). The causes were aseptic loosening in 
6, luxation of the elbow in 3, periprosthetic fracture in 1, dehiscence of triceps tendon in 1 and 
polyethylene wear in 1 cases (Table 2). With revision surgery serving as an endpoint, Kaplan-Meier 
survival analysis shows that unlinked TEAs have the mean survival time of 70 months (95% CI, 
47–94). (Fig. 3 Kaplan-Meier survival analysis) Survival time variated between 1 to 121 months.  
Complications and revisions are presented in Table 2. 
 
DISCUSSION 
The limitation of our study is that it is retrospective, and the number of the prosthesis is quite low. 
However 
in our study, we found good Mean to long-term results for elbow performance. 
MEPS stayed at high level during follow-up time. No patient had worse MEPS 
postoperatively than preoperatively.  MEPS were in line with other studies and ROM was slightly 
better in our study (3,4,14). Compared to studies for the semi-constrained prostheses, there was no 
difference in elbow performance between types of prostheses (3,15,16). We found also excellent 
results in patient satisfaction and improvement of daily function. 
In our study complication rates and revision, rates were very high for the unlinked 
prostheses. Complication rates were exact or slightly more common in our study than in most other 
studies of both types of prostheses (3,8,17). All the complications that occurred in our study are 
common with total elbow arthroplasties despite the type of prosthesis (4,9,18). In our study, we 
found very high revision rate compared to most other studies (2,3,8). Two studies showed worse 
results than ours for complication rates and revision rates (4,19). Two early revisions, after 1 month 
and 3 months from primary surgery, have most likely worsened our results and most revisions 
occurred during years. Typical complications and indications for revision were the same in most of 
the studies for both types of prostheses (2,3,8). Studies show that Semi-constrained TEAs have 
better results for implant survival (2,3,8,20). Compared to knee and hip prostheses studies show that 
TEAs have much more complications and higher revision rates (21,22).  
Radiolucency occurred in high percentage. Most of the patients with radiological 
loosening had no symptoms and radiological loosening rarely led to revision. Radiological 
loosening was most common in the distal end of the humeral component and the proximal end of 
the ulnar component. 
High rates of complications and revisions stay unclear. High rates might be explained 
trough long follow up time, cementing techniques and the quality of cement used. In other studies, 
the follow up time have been shorter and, in our study, the most revisions occurred towards the end 
of follow up, which might explain high rates. For ulnar component there are no commercial plugs, 
so the plugs used are made by modifying other plugs or there is no plug used at all. This may lead 
to unperfect cementing and may be the reason for loosening of ulnar component. Also, the 
condition of patients with RA have been significantly developed due advancements in medication 
which may distort our results compared to studies with newer patients. 
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CONCLUSION 
Unlinked total elbow arthroplasties provide excellent results for improving elbow functionality and 
significantly increase the quality of life, but complication and revision rates are high. Semi-
constrained models have better results and it is advisable to prefer semi-constrained models over 
unlinked models. Compared to other common arthroplasties such as knee and hip arthroplasties 
TEAs have much more complications and much shorter survival times. Further development of 
TEAs is needed to decrease complication and revision rates. 
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Fig 1. Areas of radiolucency: 
 
Fig. 2. Mean MEPS during follow up: 
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Fig. 3. Kaplan-Meier survival analysis. 
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